Profusa (NVACW) Shares Outstanding (Diluted Average) (2021 - 2026)
Profusa (NVACW) reported Shares Outstanding (Diluted Average) of $1.7 million for Q1 2026, up 6431.91% on a YoY basis from $25844.0 in Q1 2025, and up 404.27% quarter-over-quarter from $334762.0 in Q4 2025.
Profusa (NVACW) Shares Outstanding (Diluted Average) (2021 - 2026) Analysis & Trends
Profusa has reported Shares Outstanding (Diluted Average) for 6 years, with the latest figure at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Shares Outstanding (Diluted Average) rose 6431.91% year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (up 6431.91% YoY), and the FY2025 full-year result was $334762.0, up 1195.32% from the prior year.
- Shares Outstanding (Diluted Average) for Q1 2026 stood at $1.7 million, up from $334762.0 in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $31.7 million in Q3 2025, with the low at $25844.0 in Q4 2024.
- Historically, Shares Outstanding (Diluted Average) has averaged $5.5 million across 5 years, with a median of $5.2 million in 2022.
- Annual changes were most pronounced in 2024 — Shares Outstanding (Diluted Average) sank 99.5% — and 2026, when it soared 6431.91%.
- Profusa's Shares Outstanding (Diluted Average) stood at $5.2 million in 2022, then changed by 0.0% to $5.2 million in 2023, then slumped by 99.5% to $25844.0 in 2024, then soared by 1195.32% to $334762.0 in 2025, then jumped by 404.27% to $1.7 million in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $1.7 million (Q1 2026), $334762.0 (Q4 2025), and $31.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 1.75 Bn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 386.50 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 1.29 Bn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 1.50 Bn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 580.70 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 393.60 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 457.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | - |
| 10 | Profusa | - | - | - | 1.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.69 Mn |
| Dec 31, 2025 | 334,762.00 |
| Sep 30, 2025 | 31.73 Mn |
| Jun 30, 2025 | 5.19 Mn |
| Mar 31, 2025 | 25,844.00 |
| Dec 31, 2024 | 25,844.00 |
| Sep 30, 2024 | 1.94 Mn |
| Jun 30, 2024 | 5.19 Mn |
| Mar 31, 2024 | 5.19 Mn |
| Dec 31, 2023 | 5.19 Mn |
| Sep 30, 2023 | 5.19 Mn |
| Jun 30, 2023 | 5.19 Mn |
| Mar 31, 2023 | 5.19 Mn |
| Dec 31, 2022 | 5.19 Mn |
| Sep 30, 2022 | 5.19 Mn |
| Jun 30, 2022 | 5.19 Mn |
| Mar 31, 2022 | 5.19 Mn |
| Dec 31, 2021 | 4.17 Mn |